FDA.reportPublic FDA data

zolpidem tartrate 5 MG Sublingual Tablet

RxCUI
836647
RxNorm name
zolpidem tartrate 5 MG Sublingual Tablet
Display name
zolpidem tartrate 5 MG Sublingual Tablet
Full name
zolpidem tartrate 5 MG Sublingual Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:11

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EdluarZOLPIDEM TARTRATEViatris Specialty LLCa32884d0-85b5-11de-8a39-0800200c9a662022-08-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 836647

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a32884d0-85b5-11de-8a39-0800200c9a66zolpidem tartrate 5 MG Sublingual Tablet [PSN] · zolpidem tartrate 5 MG Sublingual Tablet [SCD]222These highlights do not include all the information needed to use EDLUAR safely and effectively. See full prescribing information for EDLUAR. EDLUAR ® (zolpidem tartrate) sublingual tablets, for oral use, CIV Initial U.S. Approval: 199220220815